210
Participants
Start Date
Not specified
Study Completion Date
July 31, 1995
Glycovir
Zidovudine
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Unc Aids Crs, Chapel Hill
Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Weiss Memorial Hosp., Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
USC CRS, Los Angeles
Ucsf Aids Crs, San Francisco
University of Washington AIDS CRS, Seattle
Alabama Therapeutics CRS, Birmingham
Stanford CRS, Palo Alto
University of Colorado Hospital CRS, Aurora
Univ. of Miami AIDS CRS, Miami
Cook County Hosp. CORE Ctr., Chicago
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
Washington U CRS, St Louis
Beth Israel Med. Ctr. (Mt. Sinai), New York
Univ. of Rochester ACTG CRS, Rochester
Wake County Health and Human Services CRS, Raleigh
Univ. of Cincinnati CRS, Cincinnati
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Collaborators (2)
G D Searle
INDUSTRY
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH